FDA Probes Rare Brain Infection In Patient On Multiple Sclerosis Drug Gilenya
Tysabri is another multiple sclerosis (MS) drug associated with a high risk of PML. Demand for the drug has slowed due to
fda probes rare brain infection patient multiple sclerosis drug gilenya tysabri multiple sclerosis ms drug associate high risk pml demand drug slow